Norwest Venture Partnersled financing helps meet growing demand for scalable patient engagement platform
Courier Health, a technology company reimagining how life science manufacturers engage and support patients, announced a $16.5 million Series A led by Norwest Venture Partners with participation from existing investor WorkBench. The funding will support continued product innovation and hiring across engineering and sales to bring the companys purposebuilt customer relationship management (CRM) platform to more biopharma partners in search of a comprehensive system for coordinating and personalizing the patient journey.
Specialty medicines made up 93% of all drug approvals and the vast majority of R&D pipelines last year, leading biopharma companies to build internal organizations for access, affordability, and adherence support for these therapies. However, they lack the specialized technology and datadriven visibility to coordinate efficiently across stakeholders.
Courier Health provides a patientbased CRM platform for biopharma field access, patient services, and marketing teams to gain complete visibility and control over the patient journey. The platform connects data sets, enabling centralized patient and provider management, workflow automation, and analytics. Companies partnering with Courier Health have seen improvements in patient starts, timetostart, and ongoing adherence to therapies.
Danny Sigurdson, founder and CEO of Courier Health, emphasized the importance of enhancing the patient experience for those prescribed specialty medicines, with stats showing that 60% to 70% of patients either do not start or discontinue their medications within the first few months.
Irem Rami, principal at Norwest Venture Partners, highlighted the demand for a CRM solution tailored for the biopharma industry and praised Courier Healths platform for enabling personalized patient engagement at scale. Norwest Venture Partners led the Series A funding round, with WorkBench as an existing investor.
Article